ARCHIVES

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Roanoke Awarded CHOP Contract

May 29, 1981

“Cancer Is a Disappearing Disease” and Other Controversies

January 3, 1986

NIH reiterates Position On Closed Meeting Of BSC Chairmen

September 23, 1994

Norris Cotton Cancer Center wins core grant renewal.

October 10, 2003

ACS Funds Pilot Study Of Mammography Trial

July 28, 1995

Genentech’s Ferrara Wins Lasker Award For VEGF Discovery

October 8, 2010